Long-Term Efficacy and Safety of Luspatercept for Treating Anemia in Lower-Risk Myelodysplastic Syndromes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study
J. Clin. Oncol 2022 Aug 23;[EPub Ahead of Print], U Platzbecker, KS Götze, P Kiewe, U Germing, K Mayer, M Radsak, T Wolff, J Chromik, K Sockel, U Oelschlägel, D Haase, T Illmer, HK Al-Ali, G Silling, JG Reynolds, X Zhang, KM Attie, JK Shetty, A GiagounidisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.